Global Parkinson’s Disease Drug Market to be driven at a CAGR of 7.9% in the Forecast Period of 2021-2026

Business Healthcare and Pharmaceutical News

The new report by Expert Market Research titled, ‘Global Parkinson’s Disease Drug Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global Parkinson’s disease drug market, assessing the market based on its segments like drug class, route of administration, distribution channel, end use, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin America. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Note 1: For a snapshot of the primary and secondary data of the market (2015-2025), along with business strategies and detailed market segmentation, please click on the request sample report. The sample report shall be delivered to you within 24 hours.

Request a free sample copy in PDF or view the report summary@

The key highlights of the report include:

Market Overview (2021-2026)

  • Historical Market Size (2020): USD 5.32 Billion
  • Forecast CAGR (2021-2026): 7.9%
  • Forecast Market Size (2026): USD 8.4 Billion

The global Parkinson’s disease drug market is driven by the rising prevalence of neurodegenerative diseases in geriatric population. The growing geriatric population globally, has increased the incidences of Parkinson’s disease. Further, rising health awareness, lack of early diagnosis methods for Parkinson’s disease and investments in research and development in pharmaceutical sector are expected to push the growth in the forecast period. However, high cost of treatment may constrain the growth of the market in the forecast period.

Industry Definition and Major Segments

Parkinson’s disease is a neurogenerative disease which primarily affects geriatric population. It affects the motor capabilities, and the symptoms includes rigidity, bradykinesia, tremor, and postural instability. This disease is caused by the drop in dopamine levels due to damage of nerve cells in brain. This disease usually gets detected at a later stage due to inadequate resources for the diagnosis.

Explore the full report with the table of contents@

The Parkinson’s disease drugs market can be segmented by drug class into:

  • MAO-B Inhibitors
  • Levodopa
  • COMT Inhibitors
  • Dopamine Agonists
  • Anticholinergics
  • Others

It may be differentiated by route of administration into:

  • Oral
  • Injection
  • Transdermal

It may be divided on the basis of distribution channels into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

The market may be differentiated on the basis of end-use as:

  • Hospitals
  • Clinics
  • Others

On the basis of regional markets, the industry is divided into:

1 North America
1.1 United States of America
1.2 Canada
2 Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Others
3 Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.5 Others
4 Latin America
4.1 Brazil
4.2 Argentina
4.3 Mexico
4.4 Others
5 Middle East & Africa
5.1 Saudi Arabia
5.2 United Arab Emirates
5.3 Nigeria
5.4 South Africa
5.5 Others

Market Trends

Regionally, Europe is leading the research and development for the drug development for Parkinson’s disease. North America is expected to have the largest share in global Parkinson’s disease market. This can be attributed to presence of advance medical and pharmaceutical sector. Additionally, presence of key players in the region is expected to aid the growth in the forecast period. Meanwhile, Asia Pacific is projected to see a rapid growth owing to its developing infrastructure and pharmaceutical sector in emerging economies such as China and India. Further, the demand by growing geriatric population in the region will push the growth in the region.

Key Market Players

The major players in the market are Pfizer Inc., Medtronic plc, GlaxoSmithKline plc., AbbVie Inc., Novartis AG and a few others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Related Reports:

Global Anaemia Drugs Market Report and Forecast 2021-2026 by Expert Market Research:

Global Antiplatelet Drugs Market Report and Forecast 2021-2026 by Expert Market Research:

Global Chiropractic Software Market Report and Forecast 2021-2026 by Expert Market Research:

Global Drug Discovery and Development Solutions Market Report and Forecast 2021-2026 by Expert Market Research:

Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Report and Forecast 2021-2026 by Expert Market Research:

Global Bullous Pemphigoid Treatment Market Report and Forecast 2021-2026 by Expert Market Research:

Global Meningococcal Vaccines Market Report and Forecast 2021-2026 by Expert Market Research:

Global Neurotechnology Market Report and Forecast 2021-2026 by Expert Market Research:

Global Smart Pills Market Report and Forecast 2021-2026 by Expert Market Research:

Global Medical Wellness Market Report and Forecast 2021-2026 by Expert Market Research:

Note 2: As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

We also provide state-of-the-art procurement intelligence through our platform, Procurement Resource is a leading platform for digital procurement solutions, offering daily price tracking, market intelligence, supply chain intelligence, procurement analytics, and category insights through our thoroughly researched and infallible market reports, production cost reports, price analysis, and benchmarking.

Informes de Expertos (, the Spanish variant of Expert Market Research, is a platform that offers market research and consultancy services to a broad clientele base across Spanish speaking countries. With our primary focus on the Latin America and Spain markets, our research experts provide relevant and actionable insights into the markets and track major trends, economic developments, and global trade data.

Determined to bring client satisfaction, we make sure that our tailored approach meets the client’s unique market intelligence requirements. Our syndicated and customized research reports cover a wide spectrum of industries ranging from pharmaceuticals and food and beverage to packaging, logistics, and transportation.

Media Contact

Company Name: Expert Market Research
Contact Person: Steven Luke, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Leave a Reply

Your email address will not be published. Required fields are marked *